This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Winners and Losers: Nova Chemicals

Stocks in this article: NCX HUM

Updated from 1:07 p.m. ET

Shares of Nova Chemicals (NCX) were up $3.87, or 289%, to $5.21 Monday on news that International Petroleum Investment Co. of Abu Dhabi will buy the Canadian company for $6 a share in a $2.3 billion deal.

Nova is one of North America's top plastics and chemicals companies and gets 45% of its revenue in the U.S., 35% in Canada, and 20% in Europe and elsewhere.

"The opportunity to join IPIC comes at a good time for Nova Chemicals and will enable us to offer both stability and long-term growth to many of our stakeholders," said Jeff Lipton, Nova CEO. "IPIC is well financed and has a track record of working successfully with companies like ours."

Rosedale-Minn.-based EnteroMedics (ETRM) shares rose 45 cents, or 39.3% to $1.59 on news Friday of a $16 million private placement.

Healthspring (HS) shares plunged $4.83, or 32.6% to $9.98 after receiving a downgrade Monday by BMO Capital Markets from market perform to underperform.

Humana (HUM - Get Report) fell $9.71, or 25% to $30.83 on concerns that Medicare health care providers would be hurt after the federal government proposed a much lower-than-expected payment-rate hike for 2010.

This article was written by a staff member of TheStreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,624.95 -47.65 -0.27%
S&P 500 2,048.01 -3.81 -0.19%
NASDAQ 4,752.2660 -5.6130 -0.12%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs